Rationally designed febuxostat-based hydroxamic acid and its pH-Responsive nanoformulation elicits anti-tumor activity
- Ritika
- , Zi Yi Liao
- , Pin Yu Chen
- , N. Vijayakamasewara Rao
- , Jacob Mathew
- , Ram Sharma
- , Ajmer Singh Grewal
- , Gurpreet Singh
- , Sidharth Mehan
- , Jing Ping Liou
- , Chun Hsu Pan
- , Kunal Nepali
- TMU Research Center of Drug Discovery
- Ph.D. Program in Drug Discovery and Development Industry
- TMU Research Center of Cancer Translational Medicine
- TMU Research Center of Thoracic Medicine
- Ph. D. Program in the Clinical Drug Development of Herbal Medicine
- Ph.D. Program for Cancer Molecular Biology and Drug Discovery
- Department of Pharmaceutical Sciences
Research output: Contribution to journal › Article › peer-review
5
Link opens in a new tab
Citations
(Scopus)